Nucleic Acid Vector TRIZ Cases

Limited live-cell insight is addressed with lineage-specific multicistronic reporters for high-throughput pathway and toxicity profiling.

AAV and lentiviral vectors downregulate CMTM6 and support combination therapy for PD-L1-low or checkpoint-resistant tumors.

This case uses localized promoters to enhance cannabinoid and terpene production in tobacco and cannabis trichomes.

Cre-lox recombination with a rescue adenovirus addresses low virus conversion while enabling diverse AB-loop targeting libraries.

Oxidative E. coli cytoplasm supports disulfide-bonded antibody production above 200 mg/L.

This case integrates human variable-region genes into immunoglobulin loci to support high-affinity antibodies with reduced immunogenicity.

Segmented adeno-associated virus vectors enable homologous recombination to restore CPS1 expression and control plasma ammonia levels.

Segmenting TDP-43 expression via conditional knockout resolves embryonic lethality while replicating loss-of-function phenotypes for therapeutic screening.

PiggyBac transposon vectors with inducible promoters resolve metabolic burden by separating growth from production phases, improving cell line stability.

Deleting the p6.9 gene from baculovirus prevents virion assembly, eliminating contamination that complicates downstream purification.

Segmented vector design balances cellular productivity against metabolic burden, enabling stable high-titer biologic manufacturing.

A truncated promoter retains high expression strength while enabling efficient recombinant gene production in yeast hosts.

Engineered polymerases incorporate G, C, or U into poly(A) tails to boost protein yield without complex chemical synthesis.

A nucleic acid base converting enzyme complex modifies targeted DNA sites without strand cleavage.

Low pH fermentation with recombinant Issatchenkia eliminates neutralization agents, reducing gypsum waste and operating costs.

Engineered immune cells express chimeric receptors and exogenous chemokines to recruit dendritic cells, overcoming tumor microenvironment inhibition.

Engineered light chain antibodies use histidine residues to enable pH-dependent binding and recycling.

Altering initiation codons of phosphate importer genes in Corynebacterium to increase intracellular uptake.

Segmented immunoglobulin loci in transgenic animals resolve diversity complexity trade-offs for therapeutic monoclonal antibody production.

Single baculovirus delivers rep and cap genes to simplify production, reduce genetic instability, and boost rAAV yield sixfold.

Chimeric gene construct expressing ERF and PAT1 transcription factors promotes spontaneous callus formation without exogenous hormone treatments.

CD14 promoter-driven rAAV vectors restrict gene expression to monocytes and dendritic cells, eliminating off-target effects from constitutive promoters.

Inactivating insertion sequence recognition sites prevents mutation to non-producing strains, maintaining stable cellulose output.

Lentiviral transduction of patient macrophages restores GM-CSF receptor function, clearing surfactant without general anesthesia risks.

Segmented stable cell lines produce recombinant AAV virions with controlled induction, resolving toxicity and homogeneity bottlenecks.

Deleting the polypurine tract prevents linear DNA formation, eliminating DNA damage response while enabling stable transgene expression in non-dividing cells.

Concatenating IRES and Omega sequences overcomes low translation efficiency caused by using single initiation elements.

Inverted repeat sequences inserted via CRISPR reduce polypeptide expression in hybrid plants, overcoming recessive allele limitations.

A chimeric promoter combines fiber-specific regulatory elements with a strong expression region to drive targeted gene activity in cotton.

Transcribing a specific lncRNA upstream of the Hax1 locus activates cellulase production, resolving prediction inaccuracies that limit yield.

Replacing low-yield natural extraction, these engineered enzymes provide high expression levels and uniform product quality for scalable heparin production.

Methylated plasmid DNA modulates immune responses to treat alopecia areata and other hair loss conditions.

Baculoviral expression vectors use inducible promoters to control viral protein synthesis in insect cells.

A gene transfer composition combines cationic lipids with proteins to deliver nucleic acids into cells.

siRNA therapy degrades defective mRNA encoding misfolded alpha-1-antitrypsin, resolving immunogenicity and cost barriers of augmentation treatments.

Site-specific mutations in cyclodextrin glycosyltransferase increase disproportionation activity up to 3.16 times, addressing low catalytic efficiency.

Synthetic mRNA sequences replace optimal or non-optimal codons to modulate protein expression levels through Dhh1p-dependent degradation pathways.

Replacing antibiotic markers with a beta-galactosidase fragment reduces regulatory concerns and gene silencing while maintaining stable plasmid selection.

Genetically modified Azotobacter vinelandii produces gamma-polyglutamic acid to serve as a biofertilizer.

Chemical dissolution releases viral particles via acidic contact, resolving the trade-off between high purity and operational complexity.

Transgenic swine models bridge the gap between preclinical studies and human clinical trials by accurately replicating cancer development and progression.

Episomal suicide construct prevents insertional mutagenesis by segregating maintenance and expression functions.

Conditional Cre-ERT2 recombinase inverts mutant Acvr1 exon 5 to enable controlled R206H expression in viable mice.

Replacing the native rrn operon promoter with a Vibrio natriegens rrnA variant resolves industrial scale insufficiency by boosting E. coli growth rate over 20%.

A doxycycline-inducible lentiviral vector system generates genetically homogeneous somatic cells for efficient reprogramming.

Protocatechuate decarboxylase converts mesaconic acid directly into methacrylic acid via enzymatic decarboxylation.

Multi-vector recombinase mediated cassette exchange enables targeted integration of gene sequences into host cells.

Muscle actin promoter drives ubiquitous fluorescent protein expression in insects for reliable visual identification.

Minicircle vectors eliminate plasmid backbone immunogenicity and mutation risks while enabling efficient, stable long-term protein expression.